With intense competition brewing among top European clubs, Alphonso Davies of Bayern Munich has finally made a pivotal decision regarding his future.
Johnson & Johnson (NYSE: JNJ) today announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key measures of disease activity and significant IgG reduction ...